Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-21-088841

Options or other derivatives

  • Director acquired 78,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
NEIS JOHN Director 2021-06-30 Grant or award · Stock option (right to buy) +78,000 78,000 D
Loading xslF345X03/tm2120855-5_4seq1.xml…